28th January 2022 | Pharma Updates
UAE-based company willing to invest in Indian pharma firms
Apart from Indian pharmaceutical market, Niner Pharma is also planning to get into the European market.
Covaxin, Covishield get conditional approval
DCGI approval is an upgrade from the Emergency Use Authorisation (EUA) and represents a regulatory endorsement of the safe Covid vaccine shots.
Budgetary support could impel our effort for pharmaceutical innovation
There is a much requirement for incentives to propel research and development in the Indian pharma industry.
Sanjay Nayar Resigns from JB Chemicals
He steps down as a director of JB Chemicals and Pharmaceuticals.
Sun Pharma's subsidiary launches new drug for eye treatment
Sun Pharmaceutical Industries introduces CEQUA in the Canadian market, which increases ocular tissue penetration.
FDA warns Aurobindo Pharma
According to American regulator, Aurobindo Pharma has violated good manufacturing practices at a facility in Telangana.
Glenmark receives approval for BP drugs
US FDA approved Bisoprolol Fumarate and Hydrochlorothiazide for the treatment of BP patients.